Collecting the potentially life-saving woman’s monthly menstrual flow and the umbilical cord is not something new to some of us. But here is the latest CryoCell Press Release , they announced the results of the new study showing that adding menstrual blood stems cells (MenSCs) to stems cells from umbilical cord blood expand the number of progenitor cells. Their reports explained that this expansion technique could broaden the therapeutic use of the cells and provide a more readily available supply of stem cells for transplantation.
Cryo-Cell is the first and only service that empowers women to collect and cryopreserve menstrual flow for future utilization by the donor or possible first-degree relatives. The most amazing thing is that they found out that stem cells found in cord blood have been proven to treat more than 70 life threatening illness including leukemia, neuroblastoma, lymphoma, sickle cell anemia and may also potentially be utilized with customized anti-aging, wound healing or sports medicine therapies. Their first successful cord blood stem cell transplant was last 1988, and since then, they have been using this method in more than 10,000 transplant worldwide. They promise to continue to make significant progress in advancing Cryo-Cell’s robust intellectual property portfolio of research collaborations.
MenSCs offer non-controversial and renewable stem cell source. Cryo-Cell International, Inc. is one of the largest and most established family cord blood banks. For more information about MenSCs, visit www.Celle.com.